EMA Approves First-in-Human Study for MesemCart

BIONCaRT GmbH has received approval from the responsible federal authority, the Paul Ehrlich Institute, to conduct a Phase I/IIa clinical trial. The aim of the study is to investigate the safety and initial evidence of efficacy of umbilical cord tissue-derived mesenchymal stromal cells for the treatment of cartilage damage in the knee joint. The clinical […]